Opin vísindi

Skimun fyrir krabbameinum í ristli og endaþarmi : Yfirlitsgrein um nýgengi, dánartíðni, kostnað og árangur

Show simple item record

dc.contributor Landspítali
dc.contributor.author Birgisson, Helgi
dc.contributor.author Ólafsdóttir, Elínborg J.
dc.contributor.author Sverrisdóttir, Anna
dc.contributor.author Einarsson, Sigurður
dc.contributor.author Smáradóttir, Agnes
dc.contributor.author Tryggvadóttir, Laufey
dc.date.accessioned 2021-11-19T01:01:27Z
dc.date.available 2021-11-19T01:01:27Z
dc.date.issued 2021
dc.identifier.citation Birgisson , H , Ólafsdóttir , E J , Sverrisdóttir , A , Einarsson , S , Smáradóttir , A & Tryggvadóttir , L 2021 , ' Skimun fyrir krabbameinum í ristli og endaþarmi : Yfirlitsgrein um nýgengi, dánartíðni, kostnað og árangur ' , Laeknabladid , bind. 107 , nr. 9 , bls. 398-405 . https://doi.org/10.17992/lbl.2021.09.65
dc.identifier.issn 0023-7213
dc.identifier.other PURE: 38943935
dc.identifier.other PURE UUID: 9491cf6d-000b-4b1b-b9b6-afe42cb08b06
dc.identifier.other Scopus: 85114498746
dc.identifier.uri https://hdl.handle.net/20.500.11815/2717
dc.description Publisher Copyright: © 2021 Laeknafelag Islands. All rights reserved.
dc.description.abstract In this article the incidence and mortality for cancer of the colon and rectum in Iceland is discussed. The two most common screening methods, faecal immunochemical test (FIT) and colonoscopy are compared and an estimate of cost and benefits for the Icelandic society will be made. The incidence of cancer of the colon and rectum has been increasing in Iceland in last decades but mortality has decreased and survival improved. However, more individuals die from cancer of the colon and rectum than from both breast- and cervical cancer added together. It is likely that screening for cancer of the colon and rectum, could prevent at least 6 of the 28 deaths related to those cancers, occurring yearly in Iceland in screening age, given a screening ages of 50-74 years. The extra cost for the Icelandic community due to the implementation of screening for cancer of the colon and rectum will be acceptable due to the lower cost of simpler treatments, lower cancer incidence and reduced mortality.
dc.format.extent 8
dc.format.extent 398-405
dc.language.iso is
dc.relation.ispartofseries Laeknabladid; 107(9)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Ristilkrabbamein
dc.subject Endaþarmskrabbamein
dc.subject Krabbameinsleit
dc.subject Colorectal cancer
dc.subject Cost-effectiveness
dc.subject Incidence
dc.subject Mortality
dc.subject Screening
dc.subject Læknisfræði (allt)
dc.title Skimun fyrir krabbameinum í ristli og endaþarmi : Yfirlitsgrein um nýgengi, dánartíðni, kostnað og árangur
dc.title.alternative Screening for cancer of the colon and rectumA review on incidence, mortality, cost and benefit
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/systematicreview
dc.description.version Peer reviewed
dc.identifier.doi https://doi.org/10.17992/lbl.2021.09.65
dc.relation.url http://www.scopus.com/inward/record.url?scp=85114498746&partnerID=8YFLogxK
dc.contributor.department Krabbameinsþjónusta


Files in this item

This item appears in the following Collection(s)

Show simple item record